Cover Image

History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosis

Jingbo Yu,1 Jackson Tang,2 Zhiyi Li,2 Shiva Sajjan,1 Christopher O’Regan,3 Ankita Modi,1 Vasilisa Sazonov11Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Kenilworth, NJ, USA; 2Asclepius Analytics Ltd., Wanchai, Hong Kong; 3Merck Sharp &&nbs...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu J (Author), Tang J (Author), Li Z (Author), Sajjan S (Author), O'Regan C (Author), Modi A (Author), Sazonov V (Author)
Format:	Book
Published:	Dove Medical Press, 2015-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
by: Roberto Cesareo, et al.
Published: (2009)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016)

Comparison of the Effects of Strontium Ranelate and Raloxiphene on Bone Mineral Density in Postmenopausal Osteoporosis - Original Investigation
by: Figen Yılmaz, et al.
Published: (2009)

The Short-Term Effects of Strontium Ranelate on Pain and Bone Mineral Density in Postmenopausal Women with Osteoporosis
by: Halil Koyuncu, et al.
Published: (2012)

Gastrointestinal events and association with initiation of treatment for osteoporosis
by: Modi A, et al.
Published: (2015)

Prophylactic and Therapeutic Use of Strontium Ranelate Reduces the Progression of Experimental Osteoarthritis
by: Thiago A. Rodrigues, et al.
Published: (2018)

Effect of Strontium Ranelate on Condylar Growth during Mandibular Advancement in Rats
by: Hasan Camcı, et al.
Published: (2020)

Effects of strontium ranelate on sutural bone formation: a histological and immunohistochemical study
by: Karataş Orhan H., et al.
Published: (2016)

The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
by: Figen Yılmaz, et al.
Published: (2012)

Analysis of utilization of bisphosphonates, strontium ranelate and denosumabe in Serbia, Finland, Norway and Denmark in the period 2013-2016
by: Cvjetković Đurđa M., et al.
Published: (2019)

Effects of strontium ranelate on bone formation in the mid-palatal suture after rapid maxillary expansion
by: Zhao SY, et al.
Published: (2015)

Absence of medication-related jaw osteonecrosis after treatment with strontium ranelate in ovariectomized rats
by: Leomar Emanuel de Almeida MECCA, et al.
Published: (2022)

Systemic administration of strontium ranelate to enhance the osseointegration of implants: systematic review of animal studies
by: Cassio Rocha Scardueli, et al.
Published: (2018)

Compositional and Material Properties of Rat Bone after Bisphosphonate and/or Strontium Ranelate Drug Treatment
by: Yuchin Wu, et al.
Published: (2013)

Strontium and Osteoporosis
by: Ferda Özdemir, et al.
Published: (2004)

Strontium Ranelate Elevates Expression of Heme Oxygenase-1 and Decreases Alveolar Bone Loss in Rats
by: Ricardo Basto Souza, et al.
Published: (2018)

Clinical and radiographic diagnostic study of strontium ranelate andmetal-substituted hydroxyapatite bone graft materials in diabetesmellitus with chronic periodontitis
by: Omar Khashaba, et al.
Published: (2020)

Osteoinductivity and Antibacterial Properties of Strontium Ranelate-Loaded Poly(Lactic-co-Glycolic Acid) Microspheres With Assembled Silver and Hydroxyapatite Nanoparticles
by: Zhenyang Mao, et al.
Published: (2018)

Impacto de una alerta sanitaria sobre la utilización de ranelato de estroncio Impact of a health safety warning on strontium ranelate utilization
by: Eduardo Carracedo-Martínez, et al.
Published: (2010)

Challenges in implementing and maintaining osteoporosis therapy
by: Modi A, et al.
Published: (2014)

Cardiovascular Events and Stimulants for ADHD
by: J Gordon Millichap
Published: (2011)

INTERRELATION BETWEEN CARDIOVASCULAR RISK FACTORS, OSTEOPOROSIS AND PERIODONTAL DISEASE
by: Irina Eșanu, et al.
Published: (2015)

Social isolation and risk of fatal cardiovascular events
by: Janine Gronewold, et al.
Published: (2021)

CARDIOVASCULAR PATTERN IN HIP OSTEOPOROSIS ETIOPATHOGENY- A SILENT DENTAL RISK
by: Riana Maria Huzum, et al.
Published: (2024)

Biomarkers of Adverse Cardiovascular Events in Kidney Disease
by: L. A. Kamyshnikova, et al.
Published: (2023)

Smoking and 10-year risk of cardiovascular and non-cardiovascular events after contemporary coronary stenting
by: Scott Kinlay, et al.
Published: (2024)

Cardiovascular events and additional risk in hypertensive senior citizens
by: Rosimeire Fontes de Queiroz, et al.
Published: (2014)

EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS
by: I. A. Skripnikova, et al.
Published: (2015)

EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS
by: I. A. Skripnikova, et al.
Published: (2015)

Risk of antidepressant initiation among users of cardiovascular agents and metformin.
by: Ivana Bojanić, et al.
Published: (2023)

Postmarketing pharmacovigilance: Remdesivir and cardiovascular events
by: John T. Sullivan
Published: (2022)

Testosterone replacement therapy and cardiovascular events
by: Alp Burak Çatakoğlu, et al.
Published: (2017)

Strontium Aluminate Cement Fundamentals, Manufacturing, Hydration, Setting Behaviour and Applications
Published: (2014)

Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength
by: I. A. Skripnikova, et al.
Published: (2019)

THE ROLE OF DOPING IN EMERGENCE OF ADVERSE CARDIOVASCULAR EVENTS
by: Nina Đukanović, et al.
Published: (2011)

Montelukast Use Decreases Cardiovascular Events in Asthmatics
by: Malvina Hoxha, et al.
Published: (2021)

Importance of arterial stiffness in predicting cardiovascular events
by: Ecobici Monica, et al.
Published: (2017)

Homocysteine and the Risk of Cardiovascular Events and All-Cause Death in Elderly Population: A Community-Based Prospective Cohort Study
by: Zhang Z, et al.
Published: (2020)